Crohn's disease Trials in Bankstown, Australia
Conditions / Crohn's disease / Bankstown, Australia
Clinical trials for Crohn's disease investigate a range of treatment strategies and patient populations.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01536418 | An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease | TERMINATED | PHASE3 |
| NCT01316939 | GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease | TERMINATED | PHASE3 |
| NCT00306215 | A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease | COMPLETED | PHASE2 |
| NCT03635112 | Efficacy and Safety of TD-1473 in Crohn's Disease | TERMINATED | PHASE2 |
| NCT01318993 | Open-Label Extension Study of GSK1605786A | TERMINATED | PHASE3 |
| NCT01277666 | A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease | COMPLETED | PHASE3 |
| NCT00160706 | A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease | COMPLETED | PHASE3 |
| NCT00160524 | A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] | COMPLETED | PHASE3 |
| NCT01951326 | Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease | COMPLETED | PHASE3 |
| NCT00771667 | A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy | COMPLETED | PHASE2 |